New prospects for antibacterial agents against multidrug-resistant pneumococci.
Since the first description of penicillin-resistant pneumococci nearly 30 years ago, drug-resistance has become widespread throughout the world. This review focuses upon the in vitro susceptibility of penicillin-susceptible and -resistant pneumococci to new and existing agents.
Appelbaum
P C
PC
Department of Pathology, Hershey Medical Center, PA 17033, USA.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D006801:Humans; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D000900:Anti-Bacterial Agents